Literature DB >> 12446265

Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study.

David E Laaksonen1, Hanna-Maaria Lakka, Leo K Niskanen, George A Kaplan, Jukka T Salonen, Timo A Lakka.   

Abstract

The World Health Organization (WHO) and the National Cholesterol Education Program (NCEP) recently proposed definitions for the metabolic syndrome. Little is known of their validity, however. The authors assessed the sensitivity and specificity of the definitions of the metabolic syndrome for prevalent and incident diabetes mellitus in a Finnish population-based cohort of middle-aged men (n = 1,005) followed for 4 years since the late 1980s. Four definitions based on the WHO and NCEP recommendations were compared. All definitions identified persons at high risk for developing diabetes during the 4-year follow-up (odds ratios = 5.0-8.8). The WHO definition including waist-hip ratio > 0.90 or body mass index >or= 30 kg/m(2) was the most sensitive (0.83 and 0.67) and least specific (0.78 and 0.80) in detecting the 47 prevalent and 51 incident cases of diabetes. The NCEP definition in which adiposity was defined as waist girth > 102 cm detected only 61% of prevalent and 41% of incident diabetes, although it was the most specific (0.89 and 0.90). The WHO definition seems valid as judged by its relatively high sensitivity and specificity in predicting diabetes. The NCEP definition including waist > 102 cm also identifies persons at high risk for diabetes, but it is relatively insensitive in predicting diabetes.

Entities:  

Mesh:

Year:  2002        PMID: 12446265     DOI: 10.1093/aje/kwf145

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  182 in total

1.  Effects of etanercept in patients with the metabolic syndrome.

Authors:  L Elizabeth Bernstein; Jacqueline Berry; Sunnie Kim; Bridget Canavan; Steven K Grinspoon
Journal:  Arch Intern Med       Date:  2006-04-24

Review 2.  The metabolic syndrome in children and adolescents.

Authors:  Martha L Cruz; Michael I Goran
Journal:  Curr Diab Rep       Date:  2004-02       Impact factor: 4.810

3.  Is hyperuricemia the missing piece in the metabolic syndrome puzzle?

Authors:  Zohreh Soltani; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2012-04       Impact factor: 5.369

4.  Prevalence of metabolic syndrome with International Diabetes Federation Criteria and ATP III Program in patients 65 years of age or older.

Authors:  D A De Luis; R Lopez Mongil; M Gonzalez Sagrado; J A Lopez Trigo; P F Mora; J Castrodeza Sanz
Journal:  J Nutr Health Aging       Date:  2010-05       Impact factor: 4.075

5.  World Health Organization-defined metabolic syndrome is a better predictor of coronary calcium than the adult treatment panel III criteria in American men aged 40-49 years.

Authors:  Tomoko Takamiya; Wahid R Zaky; Daniel Edmundowics; Takashi Kadowaki; Hirotsugu Ueshima; Lewis H Kuller; Akira Sekikawa
Journal:  Diabetes Care       Date:  2004-12       Impact factor: 19.112

6.  Metabolic syndrome and cognitive decline in early Alzheimer's disease and healthy older adults.

Authors:  Amber S Watts; Natalia Loskutova; Jeffrey M Burns; David K Johnson
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

7.  Genome-wide scans for heritability of fasting serum insulin and glucose concentrations in hypertensive families.

Authors:  B I Freedman; S S Rich; M M Sale; G Heiss; L Djoussé; J S Pankow; M A Province; D C Rao; C E Lewis; Y D I Chen; S R Beck
Journal:  Diabetologia       Date:  2005-03-04       Impact factor: 10.122

Review 8.  Metabolic syndrome: demographic features, etiology, and clinical management.

Authors:  Kathleen L Wyne
Journal:  Curr Atheroscler Rep       Date:  2005-09       Impact factor: 5.113

9.  Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study.

Authors:  T Tillin; N Forouhi; D G Johnston; P M McKeigue; N Chaturvedi; I F Godsland
Journal:  Diabetologia       Date:  2005-03-10       Impact factor: 10.122

10.  Unbuckling lipodystrophy from insulin resistance and hypertension.

Authors:  Robert A Hegele; Todd Leff
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.